Tag: HIVE

Monday’s Performance, 3 New Possibilities

A Good Start to the Week:

All in all, it was a good start to the fresh trading week on Monday. Our premarket report contained two quick-strike options ideas, and a couple of longer-term suggestions. Out of those four possible plays, three of them produced immediate results for us, putting up some nice intraday upswings.

Those targets were the SPY 03/18 $512-513 Calls, the TSLA Weekly $167.50-170 Calls and the ERJ 04/19 $25 Calls. Below are the intraday increases they recorded:

SPY 03/18 $512-513 Calls
$512: 2.32-3.63 (+56%)
$513: .19-.44 (+132%)
_____

TSLA Weekly $167.50-170 Calls
$167: 3.60-8.95 (+149%)
$170: 2.63-7.15 (+172%)
_____

ERJ 04/19 $25 Calls
$25: .25-.65 (+160%)

Fresh Options Ideas:
STNE Weekly $16.50-15.50 Puts
DLO 04/19 $16-15 Puts
TMP 05/17 $45-50 Calls

Li-Cycle Holdings Corp. (NYSE:LICY) – Recap: 

We’ve been tracking LICY since the morning of the 13th, and in that time, the stock has made quite a nice move in a positive direction. From its low of .6537 on the morning of our initial report, the stock has gone on to hit 1.50 in premarket trading this morning. That represents an observed run of 129% for us in just the past five trading days.

Extended Watchlist:
IHRT, HIVE, IGPK, MJNA, OTRK, ZCAR, ENVB, FUSN, HOTH, CERS

Blue Horseshoe Stocks: Bottom Plays & More

Syros Pharmaceutical, Inc. SYRS

First up on the docket for this morning is a potential bottom play that we’re going to want to put on our radars over the coming sessions. SYRS reported some less-than-ideal clinical data, and the stock got absolutely crushed yesterday.

We don’t ignore news developments, but we are constantly looking for over-abused stocks to pounce on during their recoveries, and one definitely seems in order for this play at the present juncture. The filling of the gap that was left on the chart by the sell-off would mean roughly 50% in gains from the current PPS.

Tenet Healthcare Corp. THC

We made it known yesterday morning that we had an interest in tracking the THC 01/26 $13.50-14.50 Calls as the stock appeared to be ripe for continuing its recent bottom-bounce. THC did just that, but our tracked options didn’t heat up too much yet, posting gains of just 15-24% on the day. That could be set to change today, as the stock is showing signs of a gap up and possible continued upward momentum this morning.

We’ll be sure to make monitoring the ongoing activity here one of our top priorities for the rest of this week. This may only be the beginning of THC’s rebound off of its recently established new annual lows.

Riot Blockchain, Inc. RIOT

We began tracking RIOT on November 2nd at a low of 6.33, mentioning it three times over the course of the following month. The stock saw a massive run to 21.76, for a serious move of 244%

That was followed up by a pullback to a low of 12.01 on 11/30, and since then the stock has been making a push for those highs once again, yesterday reaching 23.67. That’s an added swing of 97% on top of the previous run we witnessed, and it leaves us interested to see if the stock can re-test and possibly breach the highs off of the previous run.

Extended Watchlist:
HIVE, SPHS, PTI, ECR, SRAX, CRSP

Blue Horseshoe Stocks: PBR Updates & More

Petroleo Brasiliero SA (Petrobras) PBR – Options
–
We were pleased with the potential for quick intraday gains provided by the PBR options chain on Friday. Our thoughts on moving up our strike price turned out to be warranted, as the $12.50 and $13 Weekly Calls we mentioned both did well on the day.In fact that $13’s actually made a heck on an intraday rip from .04 to more than .20.

We’re still optimistic that PBR stock can continue to recover (after recently hitting all-time lows) and even test the 14.50-15.70 range, filling its gap on the chart. The next major resistance hurdle appears to be the  200DMA at 13.88.

As for the contracts holding our attention moving forward, we’re still looking at the May $12 Calls (which we’ve already followed from a low of .31 to Fridays high of 1.10, +255%) and also considering the June $14 Calls which closed at .47 on Friday.

Positive ID Corp. PSID

PSID is garnering our attention once again this morning. This was a winner for us when we re-alerted it back on Feb. 18th.  If you recall, the stock was trading at a low of .0572 at the time, and we’d follow it all the way up to a subsequent  high of .125. It then came back to find support off of the 200DMA in the mid-.06 range.

We observed a Golden Cross on the chart last week, a signal we are always looking out for, and an 8-K filed this morning only adds to our interest as we kick off another trading week.

It is in regard to a lucrative purchase order that the company has received from UTC Aerospace Systems, which will service the US Dept. of Defense contract for the JUPITR program (Joint United States Forces Korea Portal and Integrated Threat Recognition):
On March 28, 2014 PositiveID Corporation (the “Company” or “PositiveID”) entered into an agreement, in the form of a purchase order, from UTC Aerospace Systems (“UTAS”) to support a contract for the U.S. Department of Defense (“DoD”). This agreement is expected to be performed over the next seven months, between March and September, 2014. The terms of this fixed price agreement include a total value of $841,000 to PositiveID, paid in monthly installments over the next seven months.

This agreement will support the DoD Joint United States Forces Korea Portal and Integrated Threat Recognition (“JUPITR”) Program, which is intended to detect biological threats in order to protect our nation’s warfighters and allies. The JUPITR program will test and evaluate PositiveID’s biological detection and identification technology called M-BAND (Microfluidic Bioagent Autonomous Networked Detector). The assessment will baseline performance, reliability, maintainability, ease of use, and cost of operation to provide the “best of breed” and most affordable options for the U.S. Army and U.S. Air Force.

A copy of the agreement will be filed as an Exhibit to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. The description of certain terms of the agreement set forth herein do not purport to be complete and are qualified in their entirety by the provisions of that agreement.

Surna, Inc. SRNA

On Friday we added SRNA to our marijuana related watchlist, and were glad to have done so. We learned that SRNA’s new CEO is a former co-founder of Zynga, and the news was well received.

The stock shot out of the gate, rather quickly ballooning from its opening price of 2.99 up to 5.50 (+84%).

We also learned that in addition to a group of new directors, Surna entered into an agreement which effectively gained the company 14 intellectual property patents related to indoor climate control systems for cannabis growing in states where it is legal.

Extended Watchlist:
CLNT, MNGA, ARTX, BIOF, WATT, HIVE, PRAN (Huge gap down, possible bounce-play)